Stock listing
DRTS Stock Price, News, Filings & Events — Alpha Tau Medical Ltd
Selected listing: DRTS · NASDAQ · USD · US
This page tracks Alpha Tau Medical Ltd's DRTS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DRTS:NASDAQ. DRTS:NASDAQ is the stock-level entry point for investors researching Alpha Tau Medical Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alpha Tau Medical Ltd. is a public company traded under the ticker DRTS in the American market. The company has a market capitalization of approximately $1.12 billion. Alpha Tau focuses on innovative medical technologies, particularly in the field of cancer treatment.
- Ticker
- DRTS:NASDAQ
- Asset type
- Stock
- Market cap
- $1.30B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Alpha Tau Medical Ltd DRTS:NASDAQ stock context
This page tracks Alpha Tau Medical Ltd's DRTS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DRTS:NASDAQ. DRTS:NASDAQ is the stock-level entry point for investors researching Alpha Tau Medical Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alpha Tau Medical Ltd. is a public company traded under the ticker DRTS in the American market. The company has a market capitalization of approximately $1.12 billion. Alpha Tau focuses on innovative medical technologies, particularly in the field of cancer treatment.
Latest news from Alpha Tau Medical Ltd
Alpha Tau to Participate in September Investor Conferences
September 2, 2026
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 10, 2026
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Ban...
July 15, 2026
Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 18, 2026
Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Contro...
May 11, 2026
Research Alpha Tau Medical Ltd
Alpha Tau Medical Ltd investor report
Review AI stock analysis and investor report context for DRTS:NASDAQ.
Alpha Tau Medical Ltd company profile
View the public company page for Alpha Tau Medical Ltd on 6ix.
Alpha Tau Medical Ltd news
Read company news and market updates connected to Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd investor events
Find investor webinars, events, and replay context for Alpha Tau Medical Ltd.